Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age With Refractory Epilepsy

Drugs in R and D - United Kingdom
doi 10.2165/11636260-000000000-00000
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lacosamide in Patients With Epilepsy of Cerebrovascular Etiology

Acta Neurologica Scandinavica
MedicineNeurology
2020English

Perampanel Efficacy and Tolerability With Enzyme-Inducing AEDs in Patients With Epilepsy

Neurology
Neurology
2015English

Efficacy and Tolerability of Low-Dose Perampanel in Patients With Childhood-Onset Intractable Epilepsy

Annals of Child Neurology
2019English

PND34 Cost-Utility Analysis of Lacosamide Adjunctive Therapy in the Treatment of Patients With Refractory in the Slovak Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Tocilizumab in Refractory Rheumatoid Arthritis: Long-Term Efficacy, Safety, and Tolerability Beyond 2 Years

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2016English

Russian Experience of Lacosamide (Vimpat) Usage in Treatment of Uncontrolled Focal Epilepsy

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

Practice Guideline Update Summary: Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-Resistant Epilepsy

Neurology
Neurology
2018English

Practice Guideline Update Summary: Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-Resistant Epilepsy

Epilepsy Currents
Neurology
2018English

Switching From Traditional Sodium Channel Blockers to Lacosamide in Patients With Epilepsy

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy